和α-synuclein在Lewy体疾病中的明显亚细胞局部化
D Luke Fischer1, Marissa Menard2, Omar Z Abdelaziz2
1Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA. david.fischer2@ucsf.edu.
Acta neuropathologica communications
|January 21, 2025
概括
阿尔法-同核素和陶蛋白经常在莱维体病 (LBD) 中共存. 这项研究发现,大脑组织中α-synuclein和tau之间的直接局部化有限,这表明直接相互作用最小.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
- 免疫学 免疫学 免疫学
背景情况:
- 莱维体 (α-synuclein) 和神经纤维状 (tau) 是神经退行性疾病的标志性病理.
- 这些病理往往与认知能力下降并存并相关.
- 在莱维体病 (LBD) 中,对α-synuclein和tau的同位定位的量化是有限的.
研究的目的:
- 研究死后脑组织中α-synuclein和tau的局部化,这些脑组织来自患有和没有勒维体病 (LBD) 的个体.
- 为了检查这些蛋白质聚合物和神经炎症标志物之间的关系.
主要方法:
- 死后中回组织的免疫光标记.
- 使用的抗体:酸化α-synuclein (p-α-syn),酸化tau (p-tau),tau的酸酶激活域 (PAD-tau),MHCII和Iba1.
- 蛋白质局部化的量化和与LBD诊断的关联.
主要成果:
- 丰富的p-α-syn,p-tau和MHCII与LBD诊断有显著的相关性.
- 激活的免疫细胞 (微细胞) 显示MHCII和Iba1.1的同位化.
- p-α-syn很少与p-tau或PAD-tau同位,但与PAD-tau的重叠与LBD有关.
- 当tau存在于同一个Lewy体/神经质中时,它似乎包围了α-syn.
结论:
- 尽管在LBD中经常共存,但在中圈中,α-synuclein和tau在相同的病理结构中的直接蛋白质与蛋白质相互作用是罕见的.
- 这些发现表明,这些病理之间的关系可能是间接的,或通过不同的机制发生.
- 需要进一步的研究来充分阐明α-synuclein,tau和神经炎症在LBD进展中的复杂相互作用.
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K


